---
schema_version: "secwatch.filing_event.v1"
accession: "0001006837-23-000062"
form_type: "8-K"
ticker: "VATE"
cik: "0001006837"
company_name: "INNOVATE Corp."
filed_at: "2023-05-10T23:59:59+00:00"
generated_at: "2026-06-15T05:40:00.279065+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# INNOVATE Q1 revenue down 23% to $317.9M; adj. EBITDA $4.9M vs $11.5M

## Summary
- Net loss attributable to common $10.2M ($0.13/shr) improved from $13.6M loss ($0.18/shr).
- Infrastructure revenue $311.7M (-22.5%); adj. EBITDA $16.3M vs $20.5M; backlog $1.6B.
- Life Sciences: R2 shipped 273 GLACIAL devices, three new FDA clearances; MediBeacon submission Q2.
- Spectrum revenue $5.7M (down 42%) as Azteca ended; adj. EBITDA $0.4M vs $1.3M.
- Cash $16.6M (from $80.4M year-end); drew $8M on revolver post-quarter to $13M.

## SEC filing metadata
- accession: 0001006837-23-000062
- form_type: 8-K
- ticker: VATE
- cik: 0001006837
- company_name: INNOVATE Corp.
- filed_at: 2023-05-10T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1006837/000100683723000062/0001006837-23-000062-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1006837/000100683723000062/hchc-20230510.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001006837-23-000062
- JSON: https://secwatch.observer/filing/0001006837-23-000062.json
- Plain text: https://secwatch.observer/filing/0001006837-23-000062.txt

## Key facts
- Earnings Releases
  INNOVATE Corp. reported three months ended March 31, 2023 results: revenue $317.9 million, net income $(10.2) million, EPS $(0.13) per fully diluted share.
  - Period: three months ended March 31, 2023
  - Revenue: $317.9 million
  - Net income: $(10.2) million
  - EPS: $(0.13) per fully diluted share
  - Result: reported results
  source text: to enhance patient outcomes. And at Spectrum, we continue to expect better profitability in that business once the new channels are at run rate." “We achieved revenue of $317.9 million and adjusted EBITDA of $4.9 million amid a difficult first quarter operating environment for our businesses,” said Wayne Barr, Jr., Chief Executive Officer of INNOVATE. “In
  evidence_url: https://www.sec.gov/Archives/edgar/data/1006837/000100683723000062/0001006837-23-000062-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.